Table 1. Relationships between BCL11A-XL expression and clinicopathological factors.
| Parameters | BCL11A-XL (%) |
P value | |
|---|---|---|---|
| Positive 19 (47.5) | Negative 21 (52.5) | ||
| Histology type | 0.006 | ||
| SCC | 12 (44.4) | 15 (55.6) | |
| LCC | 7 (87.5) | 1 (22.5) | |
| AC | 0 (0.0) | 5 (100.0) | |
| Smoking status | 0.049 | ||
| NO | 8 (72.7) | 3 (14.3) | |
| Yes | 11 (37.9) | 18 (62.1) | |
| Gender | 0.085 | ||
| Male | 14 (41.2) | 20 (58.8) | |
| Female | 5 (83.3) | 1 (16.7) | |
| Stage | 0.370 | ||
| I | 11 (42.3) | 15 (57.7) | |
| II-III | 8 (57.1) | 6 (42.9) | |
| Lymph node status | 0.583 | ||
| Negative | 13 (44.8) | 16 (55.2) | |
| Positive | 6 (54.5) | 5 (45.4) | |
| Age | 0.726 | ||
| ≤65 | 11 (50.0) | 11 (50.0) | |
| >65 | 8 (44.4) | 10 (55.6) | |
BCL11A, B cell leukemia 11A; SCC, squamous cell carcinoma; LCC, large cell carcinoma; AC, adenocarcinoma.